Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesitynews2026-03-19T11:51:29+00:00March 19th, 2026|Medical Device News Magazine|
Congruence starts human trials for first drug, raises $40Mnews2026-03-19T11:00:21+00:00March 19th, 2026|Endpoints News|
Lantern raises $30M from Morgan Health, Echo Health Venturesnews2026-03-19T11:00:00+00:00March 19th, 2026|Endpoints News|
Updated: Lilly’s triple-G comparable with Mounjaro, first Phase 3 diabetes data suggestnews2026-03-19T10:45:27+00:00March 19th, 2026|Endpoints News|
